Advertisement

Cellular and Molecular Life Sciences

, Volume 67, Issue 8, pp 1343–1351 | Cite as

Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII

  • Kinga Csorba
  • Alina Sesarman
  • Eva Oswald
  • Vasile Feldrihan
  • Anja Fritsch
  • Takashi Hashimoto
  • Cassian SitaruEmail author
Research Article

Abstract

The pathomechanism of antibody-mediated tissue damage in autoimmune diseases can be best studied in experimental models by passively transferring specific autoantibodies into animals. The reproduction of the disease in animals depends on several factors, including the cross-reactivity of patient autoantibodies with the animal tissue. Here, we show that autoantibodies from patients with epidermolysis bullosa acquisita (EBA), a subepidermal autoimmune blistering disease, recognize multiple epitopes on murine collagen VII. Indirect immunofluorescence microscopy revealed that EBA patients’ IgG cross-reacts with mouse skin. Overlapping, recombinant fragments of murine collagen VII were used to characterize the reactivity of EBA sera and to map the epitopes on the murine antigen by ELISA and immunoblotting. The patients’ autoantibody binding to murine collagen VII triggered pathogenic events as demonstrated by a complement fixing and an ex vivo granulocyte-dependent dermal–epidermal separation assay. These findings should greatly facilitate the development of improved disease models and novel therapeutic strategies.

Keywords

Autoimmunity Autoantigen Basement membrane zone Collagen Extracellular matrix 

Notes

Acknowledgments

The authors acknowledge support by grants from the Deutsche Forschungsgemeinschaft SI-1281/2-1, SI-1281/4-1 and BIOSS-B13 (CS), from the Medical Faculty of the University of Freiburg (C.S.) and by an ERASMUS stipend (V.F.). We thank Dr. Leena Bruckner-Tuderman, Freiburg, Germany, for critical reading of the manuscript and helpful advice.

Supplementary material

18_2009_256_MOESM1_ESM.doc (52 kb)
Supplementary material 1 (DOC 51 kb)
18_2009_256_MOESM2_ESM.doc (28 kb)
Supplementary material 2 (DOC 27 kb)
18_2009_256_MOESM3_ESM.tif (13.3 mb)
Supplementary Fig. 1 Expression of the recombinant GST-fusion and His-tagged fragments of murine collagen VII. (a) Equimolar amounts of GST (lane 2), GST-mCVII-1 (lane 3), GST-mCVII-2 (lane 4), GST-mCVII-3 (lane 5), GST-mCVII-4 (lane 6), GST-mCVII-5 (lane 7), GST-mCVII-Z (lane 8), GST-mCVII-Cr (lane 9) as well as (b) His-DHFR (lane 2), His-mCVII-1 (lane 3), His-mCVII-2 (lane 4), His-mCVII-3 (lane 5), His-mCVII-4 (lane 6), His-mCVII-5 (lane 7), His-mCVII-Z (lane 8) and His-mCVII-Cr (lane 9) were separated by 12% SDS-PAGE and stained with BioSafe Coomassie blue. The GST and His labelled proteins migrated according to their expected molecular weight. (c) The His-DHFR (lane 1) and the His tagged recombinant murine collagen VII fragments (lanes 2-8) were separated on a 12% polyacrylamide gel. Immunoblot analysis with a mouse IgG raised against RGS-His (Qiagen), in a first step, and with a HRP conjugated anti mouse antibody (BioRad) in a second step resulted in detection of all His labelled proteins. (TIF 13.2 kb)

References

  1. 1.
    Nishie W, Sawamura D, Goto M, Ito K, Shibaki A, McMillan J, Sakai K, Nakamura H, Olasz E, Yancey K, Akiyama M, Shimizu H (2007) Humanization of autoantigen. Nat Med 13:378–383CrossRefPubMedGoogle Scholar
  2. 2.
    Toyka KV, Brachman DB, Pestronk A, Kao I (1975) Myasthenia gravis: passive transfer from man to mouse. Science 190:397–399CrossRefPubMedGoogle Scholar
  3. 3.
    Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJ (1993) A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 92:2480–2488CrossRefPubMedGoogle Scholar
  4. 4.
    Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB (1996) Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest 98:1509–1518CrossRefPubMedGoogle Scholar
  5. 5.
    Sitaru C, Mihai S, Otto C, Chiriac MT, Hausser I, Dotterweich B, Saito H, Rose C, Ishiko A, Zillikens D (2005) Induction of dermal–epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 115:870–878PubMedGoogle Scholar
  6. 6.
    Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA (1982) Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 306:1189–1196PubMedCrossRefGoogle Scholar
  7. 7.
    Sitaru C (2009) Bullous pemphigoid: a prototypical antibody-mediated organ-specific autoimmune disease. J Invest Dermatol 129:822–824CrossRefPubMedGoogle Scholar
  8. 8.
    Mihai S, Sitaru C (2007) Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med 11:462–481CrossRefPubMedGoogle Scholar
  9. 9.
    Sitaru C, Zillikens D (2005) Mechanisms of blister induction by autoantibodies. Exp Dermatol 14:861–875CrossRefPubMedGoogle Scholar
  10. 10.
    Lapiere JC, Woodley DT, Parente MG, Iwasaki T, Wynn KC, Christiano AM, Uitto J (1993) Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 92:1831–1839CrossRefPubMedGoogle Scholar
  11. 11.
    Ishii N, Yoshida M, Hisamatsu Y, Ishida-Yamamoto A, Nakane H, Iizuka H, Tanaka T, Hashimoto T (2004) Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br J Dermatol 150:843–851CrossRefPubMedGoogle Scholar
  12. 12.
    Sitaru C, Kromminga A, Hashimoto T, Bröcker EB, Zillikens D (2002) Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal–epidermal separation in cryosections of human skin. Am J Pathol 161:301–311PubMedGoogle Scholar
  13. 13.
    Woodley DT, Ram R, Doostan A, Bandyopadhyay P, Huang Y, Remington J, Hou Y, Keene DR, Liu Z, Chen M (2006) Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol 126:1323–1330CrossRefPubMedGoogle Scholar
  14. 14.
    Sitaru C, Chiriac MT, Mihai S, Büning J, Gebert A, Ishiko A, Zillikens D (2006) Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol 177:3461–3468PubMedGoogle Scholar
  15. 15.
    Chen M, Doostan A, Bandyopadhyay P, Remington J, Wang X, Hou Y, Liu Z, Woodley DT (2007) The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. Am J Pathol 170:2009–2018CrossRefPubMedGoogle Scholar
  16. 16.
    Mihai S, Chiriac MT, Takahashi K, Thurman JM, Holers VM, Zillikens D, Botto M, Sitaru C (2007) The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita. J Immunol 178:6514–6521PubMedGoogle Scholar
  17. 17.
    Chiriac MT, Roesler J, Sindrilaru A, Scharffetter-Kochanek K, Zillikens D, Sitaru C (2007) NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol 212:56–65CrossRefPubMedGoogle Scholar
  18. 18.
    Sitaru C (2007) Experimental models of epidermolysis bullosa acquisita. Exp Dermatol 16:520–531CrossRefPubMedGoogle Scholar
  19. 19.
    Yuspa SH, Hawley-Nelson P, Koehler B, Stanley JR (1980) A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res 40:4694–4703PubMedGoogle Scholar
  20. 20.
    Olaru F, Mihai S, Petrescu I, Zillikens D, Sitaru C (2006) Generation and characterization of monoclonal antibodies against the intracellular domain of human type XVII collagen. Hybridoma 25:158–162CrossRefPubMedGoogle Scholar
  21. 21.
    Li K, Tamai K, Tan EM, Uitto J (1993) Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5′-end of the gene and the 3′-untranslated region of the mRNA. J Biol Chem 268:8825–8834PubMedGoogle Scholar
  22. 22.
    Sitaru C, Schmidt E, Petermann S, Munteanu LS, Bröcker E, Zillikens D (2002) Autoantibodies to bullous pemphigoid antigen 180 induce dermal–epidermal separation in cryosections of human skin. J Invest Dermatol 118:664–671CrossRefPubMedGoogle Scholar
  23. 23.
    Sesarman A, Sitaru AG, Olaru F, Zillikens D, Sitaru C (2008) Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita. J Mol Med 86:951–959CrossRefPubMedGoogle Scholar
  24. 24.
    Sitaru C, Powell J, Messer G, Bröcker E, Wojnarowska F, Zillikens D (2004) Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obstet Gynecol 103:757–763PubMedGoogle Scholar
  25. 25.
    Sesarman A, Mihai S, Chiriac MT, Olaru F, Sitaru AG, Thurman JM, Zillikens D, Sitaru C (2008) Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice. Br J Dermatol 158:463–471CrossRefPubMedGoogle Scholar
  26. 26.
    Mihai S, Chiriac MT, Herrero-González JE, Goodall M, Jefferis R, Savage COS, Zillikens D, Sitaru C (2007) IgG4 autoantibodies induce dermal–epidermal separation. J Cell Mol Med 11:1117–1128CrossRefPubMedGoogle Scholar
  27. 27.
    Smith TF, Waterman MS (1981) Identification of common molecular subsequences. J Mol Biol 147:195–197CrossRefPubMedGoogle Scholar
  28. 28.
    Kolaskar A, Tongaonkar P (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276:172–174CrossRefPubMedGoogle Scholar
  29. 29.
    Shimanovich I, Mihai S, Oostingh GJ, Ilenchuk TT, Bröcker E, Opdenakker G, Zillikens D, Sitaru C (2004) Granulocyte-derived elastase and gelatinase B are required for dermal–epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 204:519–527CrossRefPubMedGoogle Scholar
  30. 30.
    Woodley DT, Chang C, Saadat P, Ram R, Liu Z, Chen M (2005) Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 124:958–964CrossRefPubMedGoogle Scholar
  31. 31.
    Li K, Christiano AM, Copeland NG, Gilbert DJ, Chu ML, Jenkins NA, Uitto J (1993) cDNA cloning and chromosomal mapping of the mouse type VII collagen gene (Col7a1): evidence for rapid evolutionary divergence of the gene. Genomics 16:733–739CrossRefPubMedGoogle Scholar
  32. 32.
    Tanaka T, Furukawa F, Imamura S (1994) Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen. J Invest Dermatol 102:706–709CrossRefPubMedGoogle Scholar
  33. 33.
    Gandhi K, Chen M, Aasi S, Lapiere JC, Woodley DT, Chan LS (2000) Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype. J Clin Immunol 20:416–423CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag, Basel/Switzerland 2010

Authors and Affiliations

  • Kinga Csorba
    • 1
    • 2
  • Alina Sesarman
    • 1
  • Eva Oswald
    • 1
    • 2
  • Vasile Feldrihan
    • 1
  • Anja Fritsch
    • 1
  • Takashi Hashimoto
    • 3
  • Cassian Sitaru
    • 1
    • 4
    Email author
  1. 1.Department of DermatologyUniversity of FreiburgFreiburgGermany
  2. 2.Faculty of BiologyUniversity of FreiburgFreiburgGermany
  3. 3.Department of DermatologyKurume UniversityKurumeJapan
  4. 4.Universitäts-Hautklinik79104FreiburgGermany

Personalised recommendations